Researchers have found that adult stem cells, previously thought to be permanent, can shed their identities and become blood cells. This discovery raises the possibility of using adult stem cells for therapeutic purposes, such as generating healthy blood cells for patients with blood disorders.
A clinical trial demonstrates that TPO, administered with G-CSF, boosts stem cell migration and increases the number of patients eligible for autologous stem cell transplantation. The treatment significantly improves re-growth of blood cells after chemotherapy.
Scientists found that adult mouse blood stem cells can survive in the early embryo and produce blood cells with embryonic features, highlighting unexpected plasticity in blood cell programming. The study challenges accepted ideas on blood cell development and opens new avenues for understanding hematopoietic cell transplantations.